The drugs industry closed the day down 0.9%. Cormedix Inc ( CRMD), Cyclacel Pharmaceuticals Inc ( CYCC), iBio Inc ( IBIO), and OxiGene Inc ( OXGN) were all winners today within the drugs industry with Valeant Pharmaceuticals International Inc ( VRX) being today's featured drugs winner. Valeant Pharmaceuticals International Inc rose $1.05 (2.9%) to $37.18 on average volume. Throughout the day, 2.8 million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.5 million shares. Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $10.8 billion and is part of the health care sector. Shares are up 27.6% year to date as of the close of trading on Tuesday. TheStreet Ratings rates Valeant Pharmaceuticals International as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and disappointing return on equity.
- You can view the full Valeant Pharmaceuticals International Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.